In scientific and technical literature, the individual components of this formulation may appear in broader research contexts involving performance modeling, recovery-associated mechanisms, or physiological resilience
Mesenchymal stem cell-derived exosomal microRNA-367-3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2
Antibodies used were as follows: FoxO3a (Cell Signaling Technology, #12829), phospho-FoxO3a (Ser253) (HUABIO, ST49-01), Atrogin-1 (Proteintech, 67172-1-Ig, RRID: AB_2882468), MuRF-1 (Proteintech, 55456-1-AP, RRID: AB_11182630), GAPDH (Proteintech, 60004-1-Ig, RRID: AB_2107436), and HRP-conjugated secondary antibodies (Proteintech, SA00001-1/SA00001-2)
The peptide can be administered subcutaneously, with some researchers using it in the same protocol alongside BPC-157 and TB-500